Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Detrol La
2. Detrusitol
3. Pha 686464b
4. Pha-686464b
5. Pha686464b
6. Tartrate, Tolterodine
7. Tolterodine
8. Tolterodine Tartrate
9. Unidet
10. Urotrol
1. Tolterodine Tartrate
2. 124937-52-6
3. Detrol La
4. Detrusitol
5. Tolterodine L-tartrate
6. Pnu-200583e
7. (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-methylphenol (2r,3r)-2,3-dihydroxysuccinate
8. Tolterodine Tartrate [usan]
9. Kabi-2234
10. Urotrol
11. 5t619tqr3r
12. Pnu 200583e
13. Tolterodine Tartrate (detrol La)
14. 124937-52-6 (tartrate)
15. Tolterodine (tartrate)
16. (r)-2-(3-diisopropylamino-1-phenyl-propyl)-p-cresol L-tartrate
17. (r)-2-(3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methylphenol (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) (salt)
18. (+)-(r)-2-(i-(2-(diisopropylamino)ethyl)benzyl)-p-cresol L-tartrate (1:1) (salt)
19. Unii-5t619tqr3r
20. (2r,3r)-2,3-dihydroxybutanedioic Acid;2-[(1r)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
21. Detrusitol Sr
22. Mfcd07771985
23. (r)-2-[3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol L-tartrate
24. Detrusitol (tn)
25. Detrol (tn)
26. Tolterodine, Tartrate
27. (tolterodine Tartrate)
28. Detrol La;kabi-2234;pnu-200583e
29. Tolterodine Tartrate,(s)
30. (r)-tolterodine L-tartrate
31. Tolterodine Tartrate- Bio-x
32. Mls003915640
33. Schembl467372
34. Chembl1200871
35. Tolterodine Tartrate (jan/usp)
36. Dtxsid80924972
37. Tolterodine Tartrate [mi]
38. Hms3715n08
39. Hms3884j08
40. Tolterodine Tartrate [jan]
41. Tolterodine Tartrate [vandf]
42. S2550
43. Tolterodine Tartrate [mart.]
44. Tolterodine Tartrate [usp-rs]
45. Akos015961803
46. Ac-2617
47. Ccg-221263
48. Cs-0441
49. Ds-1398
50. Tolterodine L-tartrate [who-dd]
51. Tolterodine L-tartrate 124937-51-5
52. (2r,3r)-2,3-dihydroxybutanedioic Acid,2-[(1r)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
53. As-35344
54. Bt164484
55. Hy-90010
56. Phenol, 2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)
57. Phenol, 2-(3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-, (r)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) (salt)
58. Smr002544692
59. Tolterodine L-tartrate, >=98% (hplc)
60. Tolterodine Tartrate [orange Book]
61. Bcp0726000292
62. Tolterodine Tartrate [ep Monograph]
63. Tolterodine Tartrate [usp Monograph]
64. Sw197495-2
65. D01148
66. (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-
67. 4-methylphenol (2r,3r)-2,3-dihydroxysuccinate
68. 937t526
69. A890340
70. J-500064
71. Q27114836
72. (+)-(r)-2-(a-[2-(diisopropylamino)ethyl]benzyl)-p-cresol Tartrate
73. (+)-r)-2-{a-(2-(diisopropylamino)ethyl)benzyl}-p-cresol Tartrate
74. (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-methylphenol(2r,3r)-2,3-dihydroxysuccinate
75. (r)-2-(3-diisopropylamino-1-phenyl-propyl)-4-methyl-phenol L-tartrate
76. 2-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol (2r,3r)-2,3-dihydroxybutanedioate
Molecular Weight | 475.6 g/mol |
---|---|
Molecular Formula | C26H37NO7 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 10 |
Exact Mass | 475.25700252 g/mol |
Monoisotopic Mass | 475.25700252 g/mol |
Topological Polar Surface Area | 139 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 474 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Detrol |
PubMed Health | Tolterodine (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | DETROL Tablets contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (R)-2-[3-[bis(1-methylethyl)-amino]1-phenylpropyl]-4-methylphenol [R-(R*,R*)]-2,3dihydroxyb... |
Active Ingredient | Tolterodine tartrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg; 1mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
2 of 6 | |
---|---|
Drug Name | Detrol la |
Drug Label | DETROL LA Capsules contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine L-hydrogen tartrat... |
Active Ingredient | Tolterodine tartrate |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 4mg; 2mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
3 of 6 | |
---|---|
Drug Name | Tolterodine tartrate |
PubMed Health | Tolterodine (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | Tolterodine tartrate tablets contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (+)-(R)-2-[I-[2-(Diisopropylamino)ethyl]benzyl]-p-cresol L-tartrate (1:1) (sa... |
Active Ingredient | Tolterodine tartrate |
Dosage Form | Tablet; Capsule, extended release |
Route | oral; Oral |
Strength | 1mg; 4mg; 2mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Apotex; Sandoz |
4 of 6 | |
---|---|
Drug Name | Detrol |
PubMed Health | Tolterodine (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | DETROL Tablets contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (R)-2-[3-[bis(1-methylethyl)-amino]1-phenylpropyl]-4-methylphenol [R-(R*,R*)]-2,3dihydroxyb... |
Active Ingredient | Tolterodine tartrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg; 1mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
5 of 6 | |
---|---|
Drug Name | Detrol la |
Drug Label | DETROL LA Capsules contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine L-hydrogen tartrat... |
Active Ingredient | Tolterodine tartrate |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 4mg; 2mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
6 of 6 | |
---|---|
Drug Name | Tolterodine tartrate |
PubMed Health | Tolterodine (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | Tolterodine tartrate tablets contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (+)-(R)-2-[I-[2-(Diisopropylamino)ethyl]benzyl]-p-cresol L-tartrate (1:1) (sa... |
Active Ingredient | Tolterodine tartrate |
Dosage Form | Tablet; Capsule, extended release |
Route | oral; Oral |
Strength | 1mg; 4mg; 2mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Apotex; Sandoz |
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Tolterodine (tartrate) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tolterodine (tartrate), including repackagers and relabelers. The FDA regulates Tolterodine (tartrate) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tolterodine (tartrate) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tolterodine (tartrate) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tolterodine (tartrate) supplier is an individual or a company that provides Tolterodine (tartrate) active pharmaceutical ingredient (API) or Tolterodine (tartrate) finished formulations upon request. The Tolterodine (tartrate) suppliers may include Tolterodine (tartrate) API manufacturers, exporters, distributors and traders.
click here to find a list of Tolterodine (tartrate) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tolterodine (tartrate) DMF (Drug Master File) is a document detailing the whole manufacturing process of Tolterodine (tartrate) active pharmaceutical ingredient (API) in detail. Different forms of Tolterodine (tartrate) DMFs exist exist since differing nations have different regulations, such as Tolterodine (tartrate) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tolterodine (tartrate) DMF submitted to regulatory agencies in the US is known as a USDMF. Tolterodine (tartrate) USDMF includes data on Tolterodine (tartrate)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tolterodine (tartrate) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tolterodine (tartrate) suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tolterodine (tartrate) Drug Master File in Korea (Tolterodine (tartrate) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tolterodine (tartrate). The MFDS reviews the Tolterodine (tartrate) KDMF as part of the drug registration process and uses the information provided in the Tolterodine (tartrate) KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tolterodine (tartrate) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tolterodine (tartrate) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tolterodine (tartrate) suppliers with KDMF on PharmaCompass.
A Tolterodine (tartrate) CEP of the European Pharmacopoeia monograph is often referred to as a Tolterodine (tartrate) Certificate of Suitability (COS). The purpose of a Tolterodine (tartrate) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tolterodine (tartrate) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tolterodine (tartrate) to their clients by showing that a Tolterodine (tartrate) CEP has been issued for it. The manufacturer submits a Tolterodine (tartrate) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tolterodine (tartrate) CEP holder for the record. Additionally, the data presented in the Tolterodine (tartrate) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tolterodine (tartrate) DMF.
A Tolterodine (tartrate) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tolterodine (tartrate) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tolterodine (tartrate) suppliers with CEP (COS) on PharmaCompass.
A Tolterodine (tartrate) written confirmation (Tolterodine (tartrate) WC) is an official document issued by a regulatory agency to a Tolterodine (tartrate) manufacturer, verifying that the manufacturing facility of a Tolterodine (tartrate) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tolterodine (tartrate) APIs or Tolterodine (tartrate) finished pharmaceutical products to another nation, regulatory agencies frequently require a Tolterodine (tartrate) WC (written confirmation) as part of the regulatory process.
click here to find a list of Tolterodine (tartrate) suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tolterodine (tartrate) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tolterodine (tartrate) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tolterodine (tartrate) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tolterodine (tartrate) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tolterodine (tartrate) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tolterodine (tartrate) suppliers with NDC on PharmaCompass.
Tolterodine (tartrate) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tolterodine (tartrate) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tolterodine (tartrate) GMP manufacturer or Tolterodine (tartrate) GMP API supplier for your needs.
A Tolterodine (tartrate) CoA (Certificate of Analysis) is a formal document that attests to Tolterodine (tartrate)'s compliance with Tolterodine (tartrate) specifications and serves as a tool for batch-level quality control.
Tolterodine (tartrate) CoA mostly includes findings from lab analyses of a specific batch. For each Tolterodine (tartrate) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tolterodine (tartrate) may be tested according to a variety of international standards, such as European Pharmacopoeia (Tolterodine (tartrate) EP), Tolterodine (tartrate) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tolterodine (tartrate) USP).
LOOKING FOR A SUPPLIER?